Sort
39,280 grants matching “leukemia”
Hypoxia-induced Metabolic Changes in Cancer
$338,163Othon Iliopoulos · Massachusetts General Hospital · R01 · FY2012 · CA
ADHESION MOLECULES MEDIATING SKIN TROPISM IN ACUTE GVHD
$338,156Brigham And Women'S Hospital · R01 · FY2002 · CA
Male germline stem cell culture and genetic modification
$338,145Ralph Lawrence Brinster · University Of Pennsylvania · R01 · FY2007 · HD
Tyrosine kinase inhibitors for the treatment of childhood AML
$338,142Sharyn D Baker · St. Jude Children'S Research Hospital · R01 · FY2012 · CA
CpG-siRNA Conjugates to Target Acute Myeloid Leukemia
$338,142Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2014 · CA
Microenvironmental Regulation of Leukemia Stem Cells
$338,142Ravi Bhatia · Beckman Research Institute/City Of Hope · R01 · FY2014 · CA
Tyrosine kinase inhibitors for the treatment of childhood AML
$338,142Sharyn D Baker · St. Jude Children'S Research Hospital · R01 · FY2011 · CA
Structural Biology of AML1 (CBFA2) and AML1-ETO
$338,141John Hackett Bushweller · University Of Virginia · R01 · FY2007 · CA
Determining the Role of DNA Methylation Deregulation in Oncogenesis
$338,128G Greg Wang · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Transcriptional Activation by Reorganizing Chromatin
$338,112Southern Illinois University Carbondale · R01 · FY2005 · GM
Structural Biology of AML1 (CBFA2) and AML1-ETO
$338,098John Hackett Bushweller · University Of Virginia · R01 · FY2006 · CA
Transcription Factor Reporter Technology
$338,092Alexei A Bogdanov · Univ Of Massachusetts Med Sch Worcester · R33 · FY2009 · CA
COG NCTN Network Group Operations Center - Year 9 Supplement
$338,058Douglas S. Hawkins · Public Health Institute · U10 · FY2022 · CA
BENZENE METABOLITES AND HEMATOTOXICITY
$338,051University Of Arizona · R01 · FY2004 · ES
Targeting Abl kinases in BRAF-driven melanomas
$338,028Rina Plattner · University Of Kentucky · R01 · FY2019 · CA
Targeted Oral Anticancer Agents: Patterns of Indicated and Off-Label Use, the Associated Factors, and Economic Implications
$338,009Ya-Chen Tina Shih · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
MICRO RNA TARGETING OF NORMAL & LEUKEMIA STEM- PROGENITOR CELLS
$337,998Curt I Civin · Johns Hopkins University · P01 · FY2008 · CA
Project 5: Transplant Conditioning for MDS and AML with Biological Agents
$337,938Judith Anne Shizuru · Stanford University · P01 · FY2019 · CA
Signal Transduction by Non-transmembrane PTPs
$337,930Benjamin G. Neel · University Health Network · R37 · FY2009 · CA
Dysregulated genome architecture in acute myeloid leukemia
$337,922David H Spencer · Washington University · R37 · FY2024 · CA
Targeting aberrant epigenetics by nanomedicine
$337,895Shujun Liu · University Of Minnesota · R01 · FY2014 · CA
Characterization of ERK8, a new MAPK in Lung
$337,875University Of Chicago · R01 · FY2003 · HL
Proteomic Approach to Further Understanding the Role of*
$337,840Children'S Hospital Boston · R01 · FY2005 · HL
Structural Studies of Nucleoprotein Complexes
$337,816Edward H. Egelman · University Of Virginia · R01 · FY2010 · GM
Prevention of quinone toxicity and mutagenicity
$337,789Anil Kumar Jaiswal · University Of Maryland Baltimore · R01 · FY2007 · ES